| 書目名稱 | Experimental Hypertension and Therapeutic Progress: Vasodilation and Beyond | | 編輯 | Bernward Garthoff,Andreas M. Knorr,Friedel Seuter | | 視頻video | http://file.papertrans.cn/319/318845/318845.mp4 | | 圖書封面 |  | | 描述 | At the workshop held in Leverkusen on December 1, 1993, Professor Dr. Stanislav Kazda was honored on the occasion of his retirement for his scientific contributions and his involvement in drug development in our company, Bayer AG. In a recent article by Eugene Garfield (Current ContentslLife Sciences 36:3-15, 1993), what most of us participating in this workshop have supposed for years was confirmed: that Kazda is one of the leading scientific authors in academia worldwide. In the said survey of citations of biomedical research articles, Kazda is number 29 in terms of actual impact, individual ~itations, and total number of published manuscripts (and this only covers the time period from 1981 to 1992). In addition, his work has contributed significantly to the number eight ranking of our company in the so-called Corporation List. With the support of colleagues inside and outside the company, Kazda made a new substance class, the 1, 4-dihydropyridines, discovered by Bossert and Vater, well known to the scientific community on a worldwide basis and established its outstanding usefulness in hypertension. He has contributed numerous publi- cations on the pharmacology of these calcium a | | 出版日期 | Conference proceedings 1995 | | 關鍵詞 | Calcium antagonists; Calciumantagonisten; Hochdruck; Pharmakologie; Stroke; hypertension; pathophysiology; | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-642-79338-7 | | isbn_softcover | 978-3-540-58545-9 | | isbn_ebook | 978-3-642-79338-7 | | copyright | Springer-Verlag Berlin Heidelberg 1995 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網安備110108008328)
GMT+8, 2025-10-13 23:43
發(fā)表于 2025-3-21 16:52:57
